The article evaluates the recent challenges faced by the pharmaceutical industry and the impact of those challenges on the product development process. Upon identification of key hurdles faced by the pharmaceutical companies during the development process, the article proposes solutions that may help to optimize the commercial opportunity of select pharmaceutical products. Although the clinical perspective is addressed, the focus of the article is on the economic perspective; specifically, strategies that pharmaceutical manufacturers can employ to maximize access and commercial viability of their pipeline products.
BlumJ. (2008) Specialty medicines led rebound in US drug approvals in 2008. Bloomberg [Online] Jan 2009, http://www.bloomberg.com, accessed 5 October 2009.
2.
DavidE.TramontinT.ZemmelR. (2009) Pharmaceutical R&D: The road to positive returns. Nature Reviews Drug Discovery8: 609–610.
SchachterA. (2007) Economic evaluation of Bayesian model to predict late-phase success of new chemical entities. Value in Health10: 377–385.
5.
NagleT. (2007) Thoughtleader: Thomas Nagle. Pharmaceutical Representative [Online]. May 2007, http://pharmexec.findpharma.com/, accessed 5 October 2009.
6.
HenryJ.Kaiser family foundation. (2009) Medicare Part D Data 2009 Data Spotlight: Specialty Tiers. [Online]. June 2009, http://www.kff.org/, accessed 2 October 2009.
7.
Code of Federal Regulations. (2009) Title 21, Vol. 5., Revised as of 1 April 2009.
RatainM. J.SargentD. J. (2009) Optimising the design of phase II oncology trials: The importance of randomization. European Journal of Cancer45: 275–280.
10.
CollierR. (2009) Drug development cost estimates hard to swallow. Canadian Medical Association Journal180(3): 279–280.
11.
YueC.ColucciP.DucharmeM. (2009) Stop costly phase III failures. Applied Clinical Trials [Serial on the Internet]18(6): 4–6, Available from: Academic Search Premier, accessed 2 October 2009.
12.
Optimal launch sequence for pharmaceuticals within the EU. M.C. Gouy Consulting GmbH 2000 May: 1–6.
13.
SandnerP.ZiegelbauerK. (2008) Product-related research: How research can contribute to successful life-cycle management. Drug Discovery Today13(9/10): 457–463.
